Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Completed · Phase 3

Conditions studied: Plaque Psoriasis

In brief

Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis

Key facts

Study ID

NCT02462122

Run by

Bausch Health Americas, Inc.

People needed

215

Starts

2015-08-19

Expected to finish

2016-11-14

Last updated by the study team

2020-08-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Valeant Site 5 — Fremont, California, United States
• Valeant Site 2 — Boynton Beach, Florida, United States
• Valeant Site 14 — North Miami Beach, Florida, United States
• Valeant Site 13 — Detroit, Michigan, United States
• Valeant Site 8 — Warren, Michigan, United States
• Valeant Site 10 — Fridley, Minnesota, United States
• Valeant Site 1 — East Windsor, New Jersey, United States
• Valeant Site 4 — Albuquerque, New Mexico, United States
• Valeant Site 12 — New York, New York, United States
• Valeant Site 6 — High Point, North Carolina, United States
• Valeant Site 3 — Portland, Oregon, United States
• Valeant Site 7 — Knoxville, Tennessee, United States
• Valeant Site 9 — College Station, Texas, United States
• Valeant Site 15 — Houston, Texas, United States
• Valeant Site 16 — Houston, Texas, United States
• Valeant Site 11 — Pflugerville, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.